Beverley Hargadon - Concepedia

Author

Beverley Hargadon

Also Known As

B Hargadon, B. Hargadon, BEVERLEY HARGADON, Beverley Hargadon, Bibek Gooptu, C Edwardson, E Hardy, E. Hardy, H.E. Hardwick, Hargadon, B.

Publications

11.4K

Citations

H-Index

Concepts

All Affiliations

Glenfield Hospital University of Leicester NIHR Leicester Biomedical Research Centre University Hospitals of Leicester NHS Trust University of Oxford

About

Beverley Hargadon is an author at Glenfield Hospital specializing in medicine, asthma, and allergy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	4.2K
2	Allergy	9	9	3.2K
3	Engineering	2	2	56
4	Public Health	2	2	39
5	Health Sciences	1	1	19

Beverley Hargadon

Publications

9.7K

Citations

H-Index

Page 1

	Year	Citations
Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma Pranabashis Haldar, Christopher E. Brightling, Beverley Hargadon, New England Journal of Medicine	2009	1.9K
Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial Ruth H. Green, Christopher E. Brightling, Susan McKenna, The Lancet AsthmaAllergyAllergy MedicineRespiratory DiseasesPulmonary Medicine	2002	1.8K
Evidence of a Role of Tumor Necrosis Factor α in Refractory Asthma Mike Berry, Beverley Hargadon, M. Shelley, New England Journal of Medicine	2006	828
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi, The Lancet Long CovidAntimicrobial StewardshipAntibioticsClinical InfectionPlatform Trial	2021	555
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet	2021	516
Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial Roshan Siva, R. H. Green, Christopher E. Brightling, European Respiratory Journal InflammationAllergyInflammatory Lung DiseaseLung InflammationRespiratory Diseases	2007	448
T <sub>H</sub> 2 and T <sub>H</sub> 17 inflammatory pathways are reciprocally regulated in asthma David F. Choy, Kevin M. Hart, Lee A. Borthwick, Science Translational Medicine AsthmaInflammatory Lung DiseaseLung InflammationImmunologyImmune Regulation	2015	438
Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study Rachael A Evans, Olivia C. Leavy, Matthew Richardson, The Lancet Respiratory Medicine	2022	407
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet Covid-19 PandemicAntiviral TherapyClinical TrialsPlatform TrialMedicine	2022	382
Increased expression of immunoreactive thymic stromal lymphopoietin in patients with severe asthma Aarti Shikotra, David F. Choy, Chandra Ohri, Journal of Allergy and Clinical Immunology AsthmaAllergyLung InflammationImmunologyImmunologic Disease	2011	323

Page 1